P30 Evaluating vancomycin continuous infusion protocol compliance and gauging therapeutic target attainment in neonates

被引：0
|
作者：
Lewis, Francesca [1 ]
Oakley, Robert [1 ,2 ]
Hatch, Jennifer [1 ]
Elst, Zoe Vander [3 ,4 ]
Smits, Anne [3 ,4 ]
Duffy, Donovan [1 ]
机构：
[1] St Georges Univ Hosp NHS Fdn Trust, London, England
[2] St Georges Univ London, London, England
[3] Univ Hosp Leuven, Leuven, Belgium
[4] Katholieke Univ Leuven, Leuven, Belgium
来源：
JAC-ANTIMICROBIAL RESISTANCE | 2023年 / 5卷 / SUPP_2期
关键词：
D O I：
10.1093/jacamr/dlad066.034
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页数：1
相关论文
共 10 条
  • [1] Vancomycin continuous infusion in neonates: dosing optimisation and therapeutic drug monitoring
    Zhao, Wei
    Lopez, Emmanuel
    Biran, Valerie
    Durrmeyer, Xavier
    Fakhoury, May
    Jacqz-Aigrain, Evelyne
    ARCHIVES OF DISEASE IN CHILDHOOD, 2013, 98 (06) : 449 - 453
  • [2] Continuous-Infusion Vancomycin in Neonates: Assessment of a Dosing Regimen and Therapeutic Proposal
    Tauzin, Manon
    Cohen, Robert
    Durrmeyer, Xavier
    Dassieu, Gilles
    Barre, Jerome
    Caeymaex, Laurence
    FRONTIERS IN PEDIATRICS, 2019, 7
  • [3] Exposure Variability and Target Attainment of Vancomycin: A Systematic Review Comparing Intermittent and Continuous Infusion
    van Maarseveen, Erik M.
    Gipmans, Suzan G. H.
    van Zanten, Arthur R. H.
    THERAPEUTIC DRUG MONITORING, 2020, 42 (03) : 381 - 391
  • [4] Protocol for a randomised controlled trial of continuous infusions of vancomycin to improve the attainment of target vancomycin levels in young infants: The VANC trial
    Gwee, Amanda
    Cranswick, Noel
    Donath, Susan M.
    Hunt, Rodney
    Curtis, Nigel
    BMJ OPEN, 2018, 8 (11):
  • [5] Do continuous vancomycin infusions achieve therapeutic target levels more often than intermittent dosing in neonates?
    Phillips, Bob
    ARCHIVES OF DISEASE IN CHILDHOOD, 2019, 104 (12) : 1229 - +
  • [6] Early Target Attainment With Continuous Infusion Meropenem and Piperacillin/Tazobactam and Utilization of Therapeutic Drug Monitoring in Critically Ill Patients: A Retrospective Cohort Study From 2017 to 2020
    Drager, Sarah
    von Rotz, Matthias
    Labhardt, Niklaus D.
    Siegemund, Martin
    Rentsch, Katharina M.
    Osthoff, Michael
    Franzeck, Fabian C.
    OPEN FORUM INFECTIOUS DISEASES, 2023, 10 (04):
  • [7] Therapeutic drug monitoring-guided continuous infusion of piperacillin/tazobactam significantly improves pharmacokinetic target attainment in critically ill patients: a retrospective analysis of four years of clinical experience
    Daniel C. Richter
    Otto Frey
    Anka Röhr
    Jason A. Roberts
    Andreas Köberer
    Thomas Fuchs
    Nikolaos Papadimas
    Monika Heinzel-Gutenbrunner
    Thorsten Brenner
    Christoph Lichtenstern
    Markus A. Weigand
    Alexander Brinkmann
    Infection, 2019, 47 : 1001 - 1011
  • [8] Therapeutic drug monitoring-guided continuous infusion of piperacillin/tazobactam significantly improves pharmacokinetic target attainment in critically ill patients: a retrospective analysis of four years of clinical experience
    Richter, Daniel C.
    Frey, Otto
    Roehr, Anka
    Roberts, Jason A.
    Koeberer, Andreas
    Fuchs, Thomas
    Papadimas, Nikolaos
    Heinzel-Gutenbrunner, Monika
    Brenner, Thorsten
    Lichtenstern, Christoph
    Weigand, Markus A.
    Brinkmann, Alexander
    INFECTION, 2019, 47 (06) : 1001 - 1011
  • [9] Therapeutic drug monitoring -guided continuous infusion of Piperacillin/Tazobactam significantly improves pharmacokinetic target-attainment in critically ill patients: a retrospective analysis from four years of clinical experience
    Richter, D. C.
    Frey, O.
    Rohr, A.
    Roberts, J. A.
    Koeberer, A.
    Fuchs, Th
    Brenner, T.
    Lichtenstein, C.
    Weigand, M. A.
    Brinkmann, A.
    INFECTION, 2019, 47 : S46 - S47
  • [10] P37 Variable adherence to and effectiveness of a vancomycin continuous infusion protocol within ICUs at a London tertiary-care hospital: a single-centre retrospective service evaluation
    Oakley, Robert
    Bakrania, Prijay
    Yau, Ting
    Standing, Joseph
    Lonsdale, Dagan
    JAC-ANTIMICROBIAL RESISTANCE, 2022, 4
1